Abstract: Autoimmune progesterone dermatitis is an uncommon, poorly recognized and under-diagnosed catamenial dermatosis associated with hypersensitivity reactions to progestagens. Most cases manifest as urticaria, eczema or erythema multiforme-like. A 26-year-old woman developed violaceous plaques on the groin and abdomen, 4 days after a spontaneous abortion resolved with uterine curettage. The lesions recurred once monthly at the same sites, mimicking a fixed drug eruption. Although the histopathology was compatible with fixed drug eruption, positive intradermal testing and symptomatic improvement after using oral contraceptive pills gave us a clue to the diagnosis.
INTRODUCTION
Autoimmune progesterone dermatitis (APD) is a rare form of hypersensitivity (HS) to progesterone (PG). It is characterized by skin lesions that occur during the luteal phase of the menstrual cycle, coinciding with peak levels of endogenous PG.
CASE REPORT
A 26-year-old female patient presented with a 5-month history of recurring skin lesions associated with itching and burning sensations. Symptoms first began 4 days after uterine curettage following a missed abortion. The patient's history was otherwise clear, except for irregular use of combined oral contraceptive pills (OCP) (levonorgestrel; ethinylestradiol).
The lesions recurred once monthly at the same sites, beginning one day prior to menstruation and resolving 3 days after the end of the menstrual cycle, leaving residual hyperpigmentation. They were initially treated with oral antihistamines and clobetasol cream, with no response. Physical examination revealed sharply demarcated violaceous plaques located at the armpits, groin, labia majora, intergluteal cleft, and abdomen (Figures 1 and 2 ).
The patient's complete blood count, erythrocyte sedimentation rate, blood biochemistry, and immunological and hormone panels were all within normal ranges.
Histopathological analysis of skin lesions was compatible with fixed drug eruption (FDE) (Figure 3 ). In light of suspicion of APD report showed that half of cases were found to manifest as urticaria, vesiculobullous eruptions, erythema multiforme, eczema, and maculopapular rashes. 1 It is noteworthy that to date, only 4 cases of FDE-like APD have been reported (Table 1) . [2] [3] [4] [5] Our patient presented with violaceous plaques always at the same sites -findings suggestive of FDE-but the periodic nature of the pathology, its relationship with menstruation, and the patient not having taken any medications led to a suspicion of APD. An analysis of the cases of FDE-like APD described in the literature found that from a histological perspective, 3 of them were compatible with adverse drug reactions (ADR).
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The diagnostic criteria for APD proposed by Warin Histology is of little help, as no specific findings have been described. It is probable that the presentation and pathogenic mechanisms depend on the type of skin manifestation affecting each patient.
The causes of APD are unknown. It has been proposed that it is an HS reaction to PG, and that it could be part of a broader syndrome of HS to some or all sex steroids (SS), including estrogens.
This intolerance is believed not to be uncommon and is thought to manifest in different ways including dermatitis, erythema multiforme, dysmenorrhea, premenstrual syndrome and mastalgia. 9 The pathogenic mechanisms of APD may be diverse and they are probably similar to HS reactions to drugs-with the participation of IgE antibodies, T cells, or proinflammatory cytokines. 9 A significant percentage of patients with APD show immediate or delayed positive reactions to intradermal tests with PG, suggesting that type I and IV HS reactions may be involved.
Given that immunological mechanisms have not been confirmed in all patients, Foer et al 8 recently suggested that this pathology should be renamed as HS to PG instead of APD, as this feature is indeed shared by all patients. They also recommend a new classification, in which patients exhibit 2 phenotypes: 1) those in whom it is triggered by endogenous PG (situations such as menstruation and pregnancy) with symptoms emerging during the luteal phase, and 2) those who had previously tolerated menstruation and in some cases even pregnancy, but symptoms emerged following exposure to exoge- Approval of the final version of the manuscript, Intellectual participation in propaedeutic and/or therapeutic conduct of the cases studied, Critical review of the manuscript
